TCL Archive Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials March 26, 1993
TCL Archive Kennedy, Waxman Disagree On Authorization Issue; Legislation For NIH, NCI This Congress Threatened September 26, 1980
TCL Archive How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval September 30, 2011
TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000